COPD clinical trials in Pennsylvania
33 studies for COPD are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50002, DuBois
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 25, 2026 · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Clinical Research Associates of Central PA, DuBois
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Sep 25, 2026 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Clinical Research Associates of Central Pennsylvania- Site Number : 8400002, DuBois
RecruitingPhase 4
Ages 40 to 85 · All sexes · Updated Sep 22, 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Temple University Hospital- Site Number : 8400059, Philadelphia
- Preferred Primary Care Physicians - Pleasant Hills- Site Number : 8400092, Pittsburgh
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Penn Medicine, Philadelphia
- Temple University, Philadelphia
- Allegheny General Hospital, Pittsburgh
- and 1 more
Recruiting
Ages 40 to 80 · All sexes · Updated Sep 17, 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, DuBois
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 15, 2026 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, DuBois
- Research Site, Philadelphia
- and 4 more
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Temple University, Philadelphia
- University of Pittsburgh, Pittsburgh
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Horsham
- Research Site, Pittsburgh
- Research Site, Sayre
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, DuBois
- Research Site, Philadelphia
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305COPD Exacerbation Follow Up
- Thomas Jefferson University, Philadelphia
RecruitingObservational study
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT07118306A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- UPMC Montefiore Hospital, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Clinical Research Associates of Central PA, LLC, DuBois
RecruitingPhase 2/3
Ages 35 to 80 · All sexes · Updated Aug 31, 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Camp Hill
- Research Site, Philadelphia
- Research Site, Philadelphia
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Aug 26, 2026 · NCT06283966To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research Associates of Central PA, LLC, DuBois
- DM Clinical Research - Philadelphia, Philadelphia
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 7, 2026 · NCT07684820STRIVE Post-Market Registry Study
- Penn State Milton S. Hershey Medical Center, Hershey
- Temple University, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- Reading Hospital, West Reading
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Jul 31, 2026 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, DuBois
- GSK Investigational Site, West Chester
RecruitingPhase 3
Ages 40 to 75 · All sexes · Updated Jul 28, 2026 · NCT07177339Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- Temple University Hospital, Philadelphia
Recruiting
Ages 22 and older · All sexes · Updated Jun 23, 2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- Temple University, Philadelphia
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 55 · All sexes · Updated Jun 3, 2026 · NCT05033990Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated May 13, 2026 · NCT05270525Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Penn Highlands - Lung Innovations/Clinical Research Associates, DuBois
- Temple University - Temple Lung Center, Philadelphia
- University of Pittsburgh Medical Center - UMPC Comprehensive Lung Center, Pittsburgh
Recruiting
Ages 40 to 80 · All sexes · Updated Apr 28, 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Clinical Research Associates of Central Pennsylvania, DuBois
- Temple University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
Recruiting
Ages 40 to 84 · All sexes · Updated Apr 24, 2026 · NCT06891755Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Apr 21, 2026 · NCT05746039Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Apr 9, 2026 · NCT06961214Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
- Thomas Jefferson University, Philadelphia
RecruitingObservational study
Ages 50 to 80 · All sexes · Updated Mar 3, 2026 · NCT06974981Supporting Evidence-based Responses to Emotional Needs in Emphysema
- University of Pennsylvania, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT06600126Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
- UPMC Presbyterian, Pittsburgh
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
RecruitingPhase 1/2
Ages 18 to 60 · All sexes · Updated Jan 13, 2026 · NCT03500731Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
RecruitingHealthy volunteers welcome
Ages 8 to 70 · All sexes · Updated Oct 24, 2025 · NCT06512064Emphysema Research Registry and Biosample Repository
- University of Pittsburgh Emphysema/COPD Research Center, Pittsburgh
RecruitingObservational studyHealthy volunteers welcome
Ages 21 and older · All sexes · Updated Sep 25, 2025 · NCT00307281Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Clinical Research Associates of Central PA, DuBois
- US Digestive Health at Lancaster, Lancaster
- Temple University, Philadelphia
- and 2 more
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077Temple Health Chest Initiative (THCI 2.0)
- Temple University Of the Commonwealth System of Higher Education, Philadelphia
RecruitingObservational studyHealthy volunteers welcome
Ages 50 to 80 · All sexes · Updated Apr 18, 2025 · NCT06933758myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- St. Luke's University Health Network, Bethlehem
- Clinical Research Associates of Central Pennsylvania, DuBois
- Jeanes Hospital, Philadelphia
- and 2 more
Recruiting
Ages 30 and older · All sexes · Updated Feb 6, 2025 · NCT05204888From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.